Protective Role of Sarpogrelate in Combination with Bromocriptine and Cabergoline for Treatment of Diabetes in Alloxan-induced Diabetic Rats

Autor: Fouad Shalaby, Mohammed, Latif, Hekma A. Abd El, Yamani, Mohamed El, Galal, May Ahmed, Kamal, Sherifa, Sindi, Ikhlas

Publikováno v: In Current Therapeutic Research 2021 95

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Therapeutic activity of sarpogrelate and dopamine D 2 receptor agonists on cardiovascular and renal systems in rats with alloxan-induced diabetes.

Autor: Fouad Shalaby MA; Pharmaceutical Sciences Department, Pharmacy Programme, Batterjee Medical College, 21442, Jeddah, Saudi Arabia, KSA. Mafrec10@yahoo.com., Abd El Latif HA; Pharmacology and Toxicology Department, Faculty of Pharmacy, Cairo University, Cairo, Egypt., El Yamani M; Pharmacology and Toxicology Department, Faculty of Pharmacy, Cairo University, Cairo, Egypt., Galal MA; Pharmacology and Toxicology Department, Faculty of Pharmacy, Cairo University, Cairo, Egypt., Kamal S; Pharmacology Department, National Organization for Drug Control and Research, Giza, Egypt., Sindi I; Research Unit, Batterjee Medical College, KSA, Jeddah, Saudi Arabia., Masaood R; Pharmaceutical Sciences Department, Pharmacy Programme, Batterjee Medical College, 21442, Jeddah, Saudi Arabia, KSA.

Publikováno v: BMC pharmacology & toxicology [BMC Pharmacol Toxicol] 2021 Oct 26; Vol. 22 (1), pp. 64. Date of Electronic Publication: 2021 Oct 26.